Actively Recruiting
Comparing Nifedipine and Enalapril for Managing Postpartum Hypertension in Women After Delivery
Led by Nebraska Methodist Health System · Updated on 2025-10-22
850
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an open-label, randomized controlled trial to compare two blood pressure medications, nifedipine and enalapril, for managing hypertension in women after childbirth. This equivalence study aims to determine if both medications are similarly safe and effective in controlling postpartum hypertension and preventing hospital readmission due to hypertensive complications. Women admitted for delivery with either chronic or pregnancy-related hypertension are eligible for participation. Participants will be randomly assigned to receive either nifedipine extended release 30mg twice daily or enalapril 10mg once daily. Treatment duration and any changes in medication dosing or additional therapies will be determined by the participants primary healthcare provider. The study focuses solely on which medication is started, with further management at the providers discretion. During the study, participants will be monitored for hospital readmission within six weeks after delivery to evaluate the effectiveness of the assigned medication. The trial will track outcomes related to blood pressure control and any complications requiring readmission. The total participation length includes the postpartum period with follow-up during these six weeks to assess safety and treatment impact.
CONDITIONS
Brief Title
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
Research Team
T
Todd Lovgren, MD
J
Joshua Dahlke, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here